EU Type II Diabetes Mellitus Drugs Market Analysis


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Europe
  • Country: Other
  • Report ID : 682

  • Format: PPT, PDF

EU Diabetes Mellitus Type-II Drugs Market: Size, Share, Growth, Trends And Segmentation by Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors, Others) and by Route of Administration (Oral, Subcutaneous, Intravenous)- Industry Analysis and Forecast (2019-2028)


Report Overview

The EU Diabetes Mellitus Type-II Drugs market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of 5.6% during the forecast period

Diabetes Mellitus Type-II is becoming an increasingly common health condition, which can disable patients and potentially lead to fatal health complications. EU spending is approximately. 9% of the total healthcare expenditure. Diabetes Mellitus Type-II is one of the leading causes of cardiovascular diseases, blindness, kidney failure, and lower limb amputation. There are about 60 million people with diabetes in the EU, or about 10.3% of men and 9.6% of women aged 25 years and over. Eating high levels of refined carbohydrates and saturated fat and not enough fruits and vegetables contributes to weight gain, thereby increasing the risk of diabetes mellitus type-II. Studies have shown that just 30 minutes of moderate exercise a day, five days a week is enough to promote good health and reduce the chance of developing diabetes mellitus type 2

Market Growth Drivers

The launch of generic versions of insulin and extensively growing demand for novel insulin in controlling blood sugar levels in type II diabetes mellitus are some of the few factors to fuel the growth in the market during the forecast period. New product launches by many key players are likely to boost the diabetes drug market growth during the forecast period. It is expected that the government support towards research & development expenditure and amendments in reimbursement policies in the healthcare is likely to drive the EU market. Further, Increasing geriatric population, adoption of a sedentary lifestyle, and uptake of unhealthy diet are some of the factors to fuel the EU Diabetes Mellitus Type-II Drugs market

1. EU Diabetes Mellitus Type-II Drugs Market Overview……………………………….
A. Market Size
2. Market Growth Drivers…………………………………….………………………………..……………..
A. Growing demand for novel insulin in controlling blood sugar
B. Rising new product launches and government reimbursement in R&D
C. Rise in adoption of a sedentary lifestyle, and increasing geriatric population
3. Diabetes Mellitus Type-II Drugs Market Segmentation……………………………
A. By Drug
I. Selective Serotonin Reuptake Inhibitors
II. DPP-4 Inhibitors
III. GLP-1 Receptor Agonists
IV. SGLT2 Inhibitors
V. Others
B. By Route of Administration
I. Oral
II. Subcutaneous
III. Intravenous
4. EU Diabetes Mellitus Type-II Drugs Market Share……………………….……………
A. Market Analysis, Insights and Forecast to 2028 by Revenue
5. Competitive Landscape………………………………………………………….………..
A. Major Players
B. Products in Pipeline
6. Key Company Profiles…………………………………………………………..………….
A. AstraZeneca PLC company overview, Product & Services, Strategies & Financials
B. Novo Nordisk company overview, Product & Services, Strategies & Financials
C. Boehringer-Ingelheim company profile, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape…………………………………….…
A. Policy changes and Reimbursement scenario
8. Potential Growth Opportunities………………………………………………..…………
A. Advancements in drug development
9. Factors Driving Future Growth…………………………………………………………..
A. Key Industry Trends and Recent Developments in EU Diabetes Mellitus Type-II Drugs
B. Future Opportunities
10. Conclusion

Market Segmentation

The EU market is segmented by Drug Class and Route of Administration

By Drug Class:

The Drug Class segment include Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors and Others. Among the Diabetes Mellitus Type-II Drugs in the EU, Insulin drugs occupy a significant market share. SGLT-2 inhibitors and DPP-4 inhibitor drugs are expected to gain a significant market share and record a high CAGR of more than 15% during the forecast period

By Route of Administration:

The EU market is segmented by Route of Administration, which is further sub segmented into Oral, Subcutaneous, and Intravenous

Top Players

The market is highly consolidated, with a few significant manufacturers having a market presence. The key manufacturers are Eli Lily, AstraZeneca, Nova Nordisk, Sanofi and Boehringer Ingelheim. Mergers and Acquisitions among major players are The European Commission approved marketing of Biocon, and the Mylan co-developed drug Insulin Glargine Semglee is boosting the demand in the Diabetes Type II Drugs market. Eli Lilly has submitted an application for Glucagon which can be administered via the nasal route in EU, on approval it can be used in the future

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements